Abstract Regulatory T (Treg) cells are potent immunosuppressors of conventional αβ T-cells in the tumor microenvironment, but how they may affect innate-like γδ T-cells remains poorly understood. Here we show that induced Treg depletion in mice selectively unleashes Vγ1+ γδ T-cells, the main subset of IFNγ-producing γδ T-cells, which are required for tumor control in an orthotopic breast cancer model. Treg cells outcompete IFNγ+ γδ T-cells for IL-2 due to increased expression of the high-affinity IL-2 receptor, thereby limiting the proliferation and effector functions of IFNγ+ γδ T-cells. Consistently, in vivo neutralization of IL-2 alongside Treg depletion abrogates the induction of IFNγ+ γδ T-cell responses, whereas administration of an IL-2Rβγc agonist circumvents Treg-mediated suppression and enhances tumor control. Finally, Treg cells also inhibit endogenous and expanded human γδ T-cells, which can be rescued by IL-2Rβγc agonism to enhance therapeutic responses in xenografted mice. Thus, bypassing Treg-mediated suppression may improve the outcome of γδ T-cell-based immunotherapies.
Silva‐Santos et al. (Wed,) studied this question.